Diffuse large B cell lymphoma with chromosomal translocation t(14;19)(q32;q13) occurring in IgG4-related disease

Ann Hematol. 2019 Jul;98(7):1785-1787. doi: 10.1007/s00277-019-03688-w. Epub 2019 Apr 13.

Authors

Affiliations

¹ Department of Medicine, Division of Hematology and Oncology, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kamigyo-ku, Kyoto, 602-8566, Japan.
² Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, 15-749 Honmachi, Higashiyama-ku, Kyoto, 605-0981, Japan.
³ Department of Pathology, Japanese Red Cross Kyoto Daiichi Hospital, 15-749 Honmachi, Higashiyama-ku, Kyoto, 605-0981, Japan.
⁴ Department of Medicine, Division of Hematology and Oncology, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kamigyo-ku, Kyoto, 602-8566, Japan. [email protected].

PMID: 31111176
DOI: 10.1007/s00277-019-03688-w

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
Carboplatin / administration & dosage
Chromosomes, Human, Pair 14 / genetics*
Chromosomes, Human, Pair 19 / genetics*
Dexamethasone / administration & dosage
Etoposide / administration & dosage
Female
Humans
Ifosfamide / administration & dosage
Immunoglobulin G4-Related Disease* / diagnostic imaging
Immunoglobulin G4-Related Disease* / drug therapy
Immunoglobulin G4-Related Disease* / genetics
Immunoglobulin G4-Related Disease* / metabolism
Lymphoma, Large B-Cell, Diffuse* / diagnostic imaging
Lymphoma, Large B-Cell, Diffuse* / drug therapy
Lymphoma, Large B-Cell, Diffuse* / genetics
Lymphoma, Large B-Cell, Diffuse* / metabolism
Positron-Emission Tomography*
Rituximab / administration & dosage
Salvage Therapy
Translocation, Genetic*

Substances

Rituximab
Etoposide
Dexamethasone
Carboplatin
Ifosfamide